Results of dry AMD pilot study show promise
February 16, 2021
LumiThera has announced positive interim data in visual and ERG clinical outcomes in the ELECTROLIGHT pilot study in dry AMD patients.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
AMD Awareness
Current and Emerging Therapies for Wet Age-Related Macular Degeneration (AMD)
March 22, 2021
Charles C. Wykoff, MD, PhD; Diana V. Do, MD; Mark P. Breazzano, MD; and Sophie J. Bakri, MD discuss the current treatment landscape for wet age-related macular degeneration (AMD) and provide insights into potential approaches to treatment in the future.
Addressing the gaps in AMD treatment
February 15, 2021
Aleksandra Rachitskaya, MD, speaks on the current gaps in AMD treatment as well as ongoing retinal advancements to help address unmeet needs of patients.
Emerging therapies in AMD management
February 07, 2021
Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.
Identifying 3 major risk factors for AMD
February 05, 2021
Joshua Mali, MD, discusses the three major risk factors for developing age-related macular degeneration (AMD).
Learning the basics of AMD
February 03, 2021
Ian C. Han, MD, dives into the basics of age-related macular degeneration (AMD) and what patients need to know.
The state of wet and dry AMD in 2021
January 28, 2021
Rishi P. Singh, MD, highlights various treatment options available for the management of patients with age-related macular degeneration, as well as the status of potential therapies.